RBC Capital lowered the firm’s price target on Omega Healthcare (OHI) to $39 from $43 and keeps a Sector Perform rating on the shares after its Q4 results. The company is better positioned to generate healthy earnings growth over the next few years and to de-lever its balance sheet, though similar to its peers, Omega is also facing sentiment pressure due to potential Medicaid cut, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare Reports Strong 2024 Financial Results
- Omega Healthcare’s Balanced Earnings Call Highlights
- Strong Q4 Performance and Strategic Moves Reinforce Buy Rating for Omega Healthcare
- Omega Healthcare reports Q4 adusted FFO 74, consensus 73c
- Omega Healthcare sees FY25 FFO $2.90-$2.98, consensus $3.02
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue